NCT01586338View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)

PHASE4CompletedINTERVENTIONAL

Enrollment

237

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Osteoarthritis

Interventions

DRUG

Hylan G-F 20

Intra-articular injection (pre-filled glass syringe)

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY